Categories: AnalyticsArtificial IntelligenceBuildingDrugFutureHealthTechLabPersonalPlatformTechnology
iLoF is enabling a new era of personalized medicine, by using AI and photonics to build a cloud-based library of diseases biomarkers.

Initially focusing a validated platform technology to on the epidemic of our times: Alzheimer’s.
Likes
589
Followers
300
Mentions
15
Location: United Kingdom, England, Oxford
Employees: 11-50
Phone: +351 22 042 6664
Total raised: $10.1M
Founded date: 2019

Investors 7

Funding Rounds 3

DateSeriesAmountInvestors
11.08.2022Seed$5MQuiet Capi...
15.07.2020-$1M-
--$4.1M-

Mentions in press and media 15

DateTitleDescription
26.08.2025Biotech Companies MilaK and iLoF Move Into Discovery Park’s CoLab in UKDiscovery Park in Kent has expanded its tenant portfolio with the addition of two early-stage biotechnology companies: MilaK, a precision fermentation protein startup, and iLoF, a digital health company working in the field of personalised ...
28.07.2022WildCard winner iLoF secures further $5MLeading digital health company, iLoF, has received $5M in funding to accelerate its mission of democratising access to personalised medicine for millions of people living with complex diseases, such as Alzheimer’s disease. Previous EIT Hea...
28.07.2022Digital health startup iLoF secures €4.89 million to accelerate personalised drug discoveryBased between Oxford and Lisbon, iLoF is a biotech startup on a mission to make a difference in the world. The company is developing a platform that creates improved access to personalised medicine for the millions of people around the worl...
28.07.2022Oxford-based iLoF bags €4M from Faber, others to accelerate personalised drug discovery and developmentOxford-based iLoF, a digital health company, announced on Thursday that it has secured $4.1M (approximately €4M) in a Seed round of funding led by Faber. US-based M12, Microsoft’s venture fund, Quiet Capital, EU-based Lunar Ventures, Alter ...
28.07.2022iLoF Raises $5M in FundingiLoF, an Oxford, UK and Porto, Portugal- based digital health company, raised $5M in funding. The $4.1m round was led by Faber, with participation from M12, Quiet Capital, Lunar Ventures, Alter Venture Partners, re.Mind Capital, and Fluxuni...
21.07.2022Startup wins first Advise & Connect Innovation AwardDuring the pandemic, we launched the Advise & Connect service as part of our wider effort as an organisation to support the research ecosystem to rapidly develop solutions to fight COVID-19. Medical researchers could come to us for spec...
17.12.2020Wild Card 2021 opens call to Europe’s innovatorsContinuing its quest to break new ground in health by challenging the status quo in areas of high unmet need, the EIT Health Wild Card programme builds game-changing life science companies. Beginning with two challenges set by EIT Health, t...
14.10.2020Introducing: The 32 companies joining Applied AI 2.0Today we are excited to introduce the 32 companies who have been selected to join Applied AI 2.0, our growth programme for tech companies with artificial intelligence at their core. Now in its second year, our Applied AI 2.0 forms part of t...
06.09.2020Meet the TC Top Picks for Disrupt 2020We’ve been extremely privileged to witness thousands of early stage startups launch and take flight at Disrupt over the past 10 years, and they just keep getting better. You’ll be hard-pressed to find more creative, game-changing startups t...
18.08.2020Amidst COVID-19, these aspiring Portuguese tech startups bagged maximum funding in 2020 so farAmidst the COVID-19 pandemic effect, the minister for the Portuguese government announced new measures to help growing tech startups. It announced €25 million to protect the tech startup ecosystem in the country. While a slew of businesses ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In